Reistone Biopharma Company Limited
15
2
2
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
6.7%
1 terminated/withdrawn out of 15 trials
87.5%
+1.0% vs industry average
27%
4 trials in Phase 3/4
29%
2 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
A Study to Evaluate the Efficacy and Safety of RSS0343 Tablets in Patients With Chronic Obstructive Pulmonary Disease
Role: lead
A Phase II Trial of the Safety and Efficacy of RSS0309 Ointment in Adults With Atopic Dermatitis
Role: lead
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of RSS0393 Ointment in Adult Patients With Plaque Psoriasis.
Role: lead
A Clinical Study of RSS0343 in Healthy Subjects
Role: lead
Evaluate the Efficacy and Safety of Topical SHR0302 Ointment in Patients With Mild-to-Moderate Atopic Dermatitis
Role: lead
Evaluate the Efficacy and Safety of SHR1459 Tablets in Patients With Primary Membranous Nephropathy
Role: lead
A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis
Role: lead
Evaluate the Efficacy and Safety of SHR0302 in Adult Patients With Severe Alopecia Areata
Role: lead
A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis.
Role: lead
Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Role: lead
A Phase II Study in Adult Patients With Moderate to Severe Atopic Dermatitis
Role: lead
An Open Label Study of the Effects of SHR1459 in NMOSDs Patients
Role: lead
A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease
Role: lead
Assess the Efficacy and Safety of SHR0302 Ointment in Adult Patients With Vitiligo
Role: lead
A Phase II Study in Patients With Alopecia Areata
Role: lead
All 15 trials loaded